Alitretinoin

Alitretinoina Ifc 10 MG Capsulas Blandas Efg

10 mg cápsula blandaSpainMarketedAuthorised 24 Apr 2019

In other countries

The same active substances on other registers, the same brand first.

HanzemaCanada · 10 MG · Capsule · DR. Reddy'S Laboratories INCSame form
HanzemaCanada · 30 MG · Capsule · DR. Reddy'S Laboratories INCSame form
ToctinoCanada · 10 MG · Capsule · Glaxosmithkline INCSame form
AlitrecareItaly · Capsula molle · Difa Cooper S.P.A.Same form
ToctinoItaly · Capsula molle · Stiefel Laboratories Legacy (Ireland) LTDSame form
Alipalmtin 10 mg zachte capsulesNetherlands · Capsule, zacht · Orifarm Healthcare A/SSame form
Alipalmtin 30 mg zachte capsulesNetherlands · Capsule, zacht · Orifarm Healthcare A/SSame form

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Alitretinoin

Alitretinoina Ifc 10 MG Capsulas Blandas Efg

10 mg cápsula blandaSpainMarketedAuthorised 24 Apr 2019

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Alitretinoïne IFC 10 mg zachte capsulesNetherlands · Capsule, zacht · Industrial Farmaceutica Cantabria S.A.

PanretinEuropean Union · Eisai GmbH

PanretinUnited States · 0.1% BASE · gel · Advanz Pharma

Packs

Pack	Code	Status
ALITRETINOINA IFC 10 MG CAPSULAS BLANDAS EFG, 30 cápsulas	725444

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Alitretinoin
Strength: 10 mg
Dosage form: cápsula blanda
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 24 Apr 2019
Registration: 84057
Marketing authorisation holder: Industrial Farmaceutica Cantabria S.A.
Procedure: National, MRP or DCP
Supply: Diagnóstico Hospitalario

TOCTINO 30 mg CAPSULAS BLANDASAlitretinoin · 30 mg · cápsula blandaSpain